Search Results 341-350 of 1241 for ⏰레고주소 [원탑보증.com/가입코드 111] 올인구조대 ⏰

1. Nesiritide in Resistant Hypertension - Clinical Trials

   About this study. The aim of this study is two fold: First the investigators want to determine the safe and most effective dose of subcutaneous (SQ) BNP in ...

2. S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer - Mayo Clinic

   The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation ...

3. Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy - Mayo Clinic

   Apixaban may stop the clotting of blood by blocking some of the enzymes needed for blood clotting. Participation eligibility. Participant eligibility includes ...

4. Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma - Mayo Clinic

   Bortezomib may help reduce the number of leukemia or lymphoma cells by blocking some of the enzymes needed for cell growth. It may also help chemotherapy work ...

5. SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease - Mayo Clinic

   About this study. To investigate the efficacy of the administration of JVS-100 delivered via direct intramuscular injections on a 3 month and 6 month ...

6. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

   This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD and elevated LDL-C despite maximum tolerated dose of LDL-C ...

7. National Biological Sample and Data Repository for Pulmonary Arterial Hypertension - Mayo Clinic

   The specific purpose of this study is to establish a national biorepository of biological samples and genetic data of patients with the World Health ...

8. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

   A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated ...

9. A Study to Assess the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice

   About this study. The purpose of this study is to evaluate an investigational, multi-cancer early detect test developed by Grail, Inc. with the results ...

10. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    The purpose of this trial is to study how well tazemetostat works in treating patients with ovarian, primary peritoneal, or endometrial cancer that has come ...